Showing results (11-20 of 79) with videos related to

Sort By:
Pageof 8
Histopathology|February 22, 2019
Anaplastic lymphoma kinase expression in small-cell lung cancerChiaki Kondoh, Yoshitsugu Horio, Yuko Hayashi, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 9, 2020
Epithelial-to-Mesenchymal Transition is a Cause of Both Intrinsic and Acquired Resistance to KRAS G12C Inhibitor in KRAS G12C-Mutant Non-Small Cell Lung CancerYuta Adachi, Kentaro Ito, Yuko Hayashi, et al.
Cancer Science|December 10, 2003
Extragonadal germ cell tumors in JapanHiromichi Ebi, Masanobu Nakata, Makoto Tahara, et al.
Nature Cancer|June 5, 2023
Scribble mis-localization induces adaptive resistance to KRAS G12C inhibitors through feedback activation of MAPK signaling mediated by YAP-induced MRASYuta Adachi, Ryo Kimura, Kentaro Hirade, et al.
Cancer Research|December 7, 2007
Novel NBS1 heterozygous germ line mutation causing MRE11-binding domain loss predisposes to common types of cancerHiromichi Ebi, Keitaro Matsuo, Nobuyoshi Sugito, et al.
Oncotarget|June 23, 2014
Receptor ligand-triggered resistance to alectinib and its circumvention by Hsp90 inhibition in EML4-ALK lung cancer cellsAzusa Tanimoto, Tadaaki Yamada, Shigeki Nanjo, et al.
Japanese Journal of Clinical Oncology|October 25, 2006
Prospective study of positron emission tomography for evaluation of the activity of lapatinib, a dual inhibitor of the ErbB1 and ErbB2 tyrosine kinases, in patients with advanced tumorsKenji Kawada, Koji Murakami, Takashi Sato, et al.
Pharmacogenetics and Genomics|May 16, 2007
Genetic polymorphisms of CYP2B6 affect the pharmacokinetics/pharmacodynamics of cyclophosphamide in Japanese cancer patientsMiki Nakajima, Sayaka Komagata, Yuto Fujiki, et al.
BMC Pulmonary Medicine|December 14, 2018
Pulmonary carcinosarcoma showing an obvious response to pazopanib: a case reportAzusa Tanimoto, Shinji Takeuchi, Hiroshi Kotani, et al.
Cancer Research|April 23, 2009
Relationship of deregulated signaling converging onto mTOR with prognosis and classification of lung adenocarcinoma shown by two independent in silico analysesHiromichi Ebi, Shuta Tomida, Toshiyuki Takeuchi, et al.
Pageof 8